{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:36:49Z","timestamp":1772890609168,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.biopha.2018.05.078","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["H201381"],"award-info":[{"award-number":["H201381"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.078","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T04:01:17Z","timestamp":1527220877000},"page":"686-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["RETRACTED: Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor"],"prefix":"10.1016","volume":"104","author":[{"given":"Kun","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Wen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.biopha.2018.05.078_bib0005","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.078_bib0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.bjc.6605493","article-title":"Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours","volume":"102","author":"Sheu","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2018.05.078_bib0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7150\/jca.13898","article-title":"MicroRNA expression profiles in papillary thyroid carcinoma, benign thyroid nodules and healthy controls","volume":"7","author":"Yoruker","year":"2016","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.078_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/thy.2010.0137","article-title":"The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years","volume":"21","author":"Hughes","year":"2011","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.biopha.2018.05.078_bib0025","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1245\/s10434-011-1733-0","article-title":"MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma","volume":"18","author":"Yip","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.078_bib0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/cncr.26500","article-title":"The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2018.05.078_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2265.2011.04162.x","article-title":"Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment","volume":"76","author":"Mulla","year":"2012","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"8","key":"10.1016\/j.biopha.2018.05.078_bib0040","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1073\/pnas.0610733104","article-title":"Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion","volume":"104","author":"Vasko","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.078_bib0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4143\/crt.2015.118","article-title":"BRAF-activated long noncoding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor","volume":"48","author":"Zheng","year":"2016","journal-title":"Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.078_bib0050","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1007\/s13277-015-4461-4","article-title":"Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance","volume":"37","author":"Lan","year":"2016","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.078_bib0055","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/hep.27239","article-title":"Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.05.078_bib0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-015-0355-8","article-title":"Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16","volume":"14","author":"Kong","year":"2015","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.078_bib0065","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s13277-015-4149-9","article-title":"Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.078_bib0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/carcin\/bgs020","article-title":"MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL","volume":"33","author":"Baraniskin","year":"2012","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.078_bib0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/jcmm.12209","article-title":"RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells","volume":"18","author":"Liu","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"33","key":"10.1016\/j.biopha.2018.05.078_bib0080","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1038\/onc.2012.403","article-title":"MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor","volume":"32","author":"Franzetti","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.078_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/0008-5472.CAN-14-2304","article-title":"miR30a inhibits LOX expression and anaplastic thyroid cancer progression","volume":"75","author":"Boufraqech","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.078_bib0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jir.2011.0084","article-title":"Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population","volume":"32","author":"Cho","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.biopha.2018.05.078_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biopha.2017.03.031","article-title":"Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma","volume":"90","author":"Deng","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.078_bib0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12943-017-0735-3","article-title":"LncRNA RP11-436H.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.078_bib0105","doi-asserted-by":"crossref","first-page":"e58879","DOI":"10.1371\/journal.pone.0058879","article-title":"Characterization of the distal polyadenylation site of the ss-adducin (Add2) pre-mRNA","volume":"8","author":"Costessi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.05.078_bib0110","doi-asserted-by":"crossref","first-page":"32189","DOI":"10.1038\/srep32189","article-title":"The long noncoding RNA ASNR regulates degradation of bcl-2 mRNA through its interaction with AUF1","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.078_bib0115","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.18632\/oncotarget.1165","article-title":"Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer","volume":"4","author":"Li","year":"2013","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.078_bib0120","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.3892\/ol.2016.4298","article-title":"B-Raf mutation and papillary thyroid carcinoma patients","volume":"11","author":"Jiang","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.078_bib0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13059-017-1368-y","article-title":"The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53\/YAP\/TEAD transcription-competent complex","volume":"18","author":"Verduci","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.078_bib0130","first-page":"48","article-title":"Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p\/RUNX2 axis","volume":"23","author":"Yu","year":"2018","journal-title":"J. BUON"},{"issue":"8","key":"10.1016\/j.biopha.2018.05.078_bib0135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/gtmb.2015.0062","article-title":"Expression levels of miR-30a-5p in papillary thyroid carcinoma: a comparison between serum and fine needle aspiration biopsy samples","volume":"19","author":"Igci","year":"2015","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.078_bib0140","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1007\/s10620-017-4763-z","article-title":"MicroRNA-30a inhibits colorectal cancer metastasis through down-regulation of type i insulin-like growth factor receptor","volume":"62","author":"Liu","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.078_bib0145","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1210\/me.2011-0065","article-title":"TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia","volume":"25","author":"Muller","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.078_bib0150","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1614265114","article-title":"THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer","volume":"114","author":"Panebianco","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2022.113817","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"record-id":"43410"},{"DOI":"10.1016\/j.biopha.2023.114552","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"record-id":"44090"},{"DOI":"10.1016\/j.biopha.2018.05.078","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}},{"DOI":"10.1016\/j.biopha.2023.114552","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000}},{"DOI":"10.1016\/j.biopha.2022.113817","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218316731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218316731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:31:23Z","timestamp":1760095883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218316731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"alternative-id":["S0753332218316731"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.078","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}